CIBC Private Wealth Group’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$912K Buy
37,697
+16
+0% +$419 ﹤0.01% 725
2025
Q3
$961K Hold
37,681
﹤0.01% 701
2025
Q2
$812K Sell
37,681
-10,487
-22% -$236K ﹤0.01% 710
2025
Q1
$994K Hold
48,168
﹤0.01% 648
2024
Q4
$1.33M Sell
48,168
-3,800
-7% -$94.6K ﹤0.01% 641
2024
Q3
$1.3M Sell
51,968
-2,100
-4% -$49.6K ﹤0.01% 637
2024
Q2
$1.11M Sell
54,068
-6,750
-11% -$131K ﹤0.01% 647
2024
Q1
$1.09M Hold
60,818
﹤0.01% 652
2023
Q4
$988K Sell
60,818
-20,500
-25% -$262K ﹤0.01% 636
2023
Q3
$1.12M Buy
81,318
+5,881
+8% +$92.7K ﹤0.01% 582
2023
Q2
$1.67M Sell
75,437
-10,000
-12% -$211K ﹤0.01% 524
2023
Q1
$1.86M Sell
85,437
-10,000
-10% -$225K ﹤0.01% 532
2022
Q4
$1.74M Sell
95,437
-5,000
-5% -$103K 0.01% 446
2022
Q3
$2.29M Sell
100,437
-19,700
-16% -$422K 0.01% 462
2022
Q2
$1.66M Hold
120,137
﹤0.01% 521
2022
Q1
$2.73M Sell
120,137
-40
-0% -$1.05K 0.01% 472
2021
Q4
$4.48M Sell
120,177
-8,500
-7% -$365K 0.01% 422
2021
Q3
$5.45M Buy
+128,677
New +$6.2M 0.01% 382

Other funds holding BLFS

CIBC Private Wealth Group's BLFS Position: Q4 2025 in Review

CIBC Private Wealth Group increased its BioLife Solutions (BLFS) stake by 0.04% in Q4 2025, buying an estimated $419 and bringing the position to 37,697 shares worth $912K. The position accounts for ﹤0.01% of the portfolio, ranked #725.

CIBC Private Wealth Group first reported a position in BLFS in Q3 2021 and has held it in 18 quarters since. The position peaked at $5.45M in Q3 2021. 187 funds tracked by Wall St. Rank hold BLFS as of Q4 2025.

  • CIBC Private Wealth Group held 37,697 shares of BioLife Solutions worth $912K as of Q4 2025.
  • CIBC Private Wealth Group bought 16 BioLife Solutions shares in Q4 2025, an estimated $419.
  • BioLife Solutions made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #725 holding.
  • CIBC Private Wealth Group first reported a position in BioLife Solutions in Q3 2021 and has held it in 18 quarters since.
  • CIBC Private Wealth Group's BioLife Solutions position peaked at $5.45M in Q3 2021.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.